Abstract
In China, influenza A(H7N9) virus appeared in 2013, then mutated into a highly pathogenic virus, causing outbreaks among poultry and cases in humans. Since September 2017, extensive use of the corresponding vaccine, H7-Re1, successfully reduced virus prevalence. However, in 2019, a novel antigenic variant emerged, posing considerable economic and public health threats.
Cite
CITATION STYLE
APA
Jiang, W., Hou, G., Li, J., Peng, C., Wang, S., Liu, S., … Liu, H. (2020). Antigenic variant of highly pathogenic avian influenza A(H7N9) Virus, China, 2019. Emerging Infectious Diseases, 26(2), 379–380. https://doi.org/10.3201/eid2602.191005
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free